Novel mechanisms of central nervous system damage in HIV infection

References

• EllisRLangfordDMasliahEHIV and antiretroviral therapy in the brain: neuronal injury and repairNature Reviews2007813344
   Web of Science ®Google Scholar
• AnthonyICRamageSNCarnieFWSimmondsPBellJEInfluence of HAART on HIV-related CNS disease and neuroinflammationJ Neuropathol Exp Neurol200564652953615977645
   PubMed Web of Science ®Google Scholar
• McArthurJCHaugheyNGartnerSHuman immunodeficiency virus-associated dementia: an evolving diseaseJ Neurovirol20039220522112707851
   PubMed Web of Science ®Google Scholar
• AntinoriAArendtGBeckerJTUpdated research nosology for HIV-associated neurocognitive disordersNeurology200769181789179917914061
   PubMed Web of Science ®Google Scholar
• AncesBMEllisRJDementia and neurocognitive disorders due to HIV-1 infectionSemin Neurol2007271869217226745
   PubMed Web of Science ®Google Scholar
• ChangLTomasiDYakupovRAdaptation of the attention network in human immunodeficiency virus brain injuryAnn Neurol200456225927215293278
   PubMed Web of Science ®Google Scholar
• AncesBMRocACWangJCaudate blood flow and volume are reduced in HIV+ neurocognitively impaired patientsNeurology200666686286616567703
   PubMed Web of Science ®Google Scholar
• DavisLEHjelleBLMillerVEEarly viral brain invasion in iatrogenic human immunodeficiency virus infectionNeurology1992429173617391513462
   PubMed Web of Science ®Google Scholar
• EugeninEABermanJWGap junctions mediate human immunodeficiency virus-bystander killing in astrocytesJ Neurosci20072747128441285018032656
   PubMed Web of Science ®Google Scholar
• WileyCASchrierRDNelsonJALampertPWOldstoneMBCellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patientsProc Natl Acad Sci U S A19868318708970933018755
   PubMed Web of Science ®Google Scholar
• ConantKTornatoreCAtwoodWMeyersKTraubRMajorEOIn vivo and in vitro infection of the astrocyte by HIV-1Adv Neuroimmunol1994432872897874397
   PubMed Web of Science ®Google Scholar
• GorryPROngCThorpeJAstrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementiaCurr HIV Res20031446347315049431
   PubMed Web of Science ®Google Scholar
• ChurchillMJWesselinghSLCowleyDExtensive astrocyte infection is prominent in human immunodeficiency virus-associated dementiaAnn Neurol200966225325819743454
   PubMed Web of Science ®Google Scholar
• JamesHJSharerLRZhangQExpression of caspase-3 in brains from paediatric patients with HIV-1 encephalitisNeuropathol Appl Neurobiol199925538038610564527
   PubMed Web of Science ®Google Scholar
• Adle-BiassetteHChretienFWingertsmannLNeuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damageNeuropathol Appl Neurobiol199925212313310216000
   PubMed Web of Science ®Google Scholar
• GiomettoBAnSFGrovesMAccumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalitiesAnn Neurol199742134409225683
   PubMed Web of Science ®Google Scholar
• AnSFGiomettoBGrovesMAxonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDSJ Neuropathol Exp Neurol19975611126212689370237
   PubMed Web of Science ®Google Scholar
• MasliahEHeatonRKMarcotteTDDendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research CenterAnn Neurol19974269639729403489
   PubMed Web of Science ®Google Scholar
• MankowskiJLSpelmanJPRessetarHGNeurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitroJ Virol19946812820282087966612
   PubMed Web of Science ®Google Scholar
• BobardtMDSalmonPWangLContribution of proteoglycans to human immunodeficiency virus type 1 brain invasionJ Virol200478126567658415163749
   PubMed Web of Science ®Google Scholar
• ArgyrisEGAcheampongENunnariGMukhtarMWilliamsKJPomerantzRJHuman immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid raftsJ Virol20037722121401215114581551
   PubMed Web of Science ®Google Scholar
• BucknerCMLuersAJCalderonTMEugeninEABermanJWNeuroimmunity and the blood–brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDSJ Neuroimmune Pharmacol20061216018118040782
   PubMed Web of Science ®Google Scholar
• AlbrightAVShiehJTItohTMicroglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolatesJ Virol19997312052139847323
   PubMed Web of Science ®Google Scholar
• LaviEKolsonDLUlrichAMFuLGonzalez-ScaranoFChemokine receptors in the human brain and their relationship to HIV infectionJ Neurovirol1998433013119639073
   PubMed Web of Science ®Google Scholar
• GabuzdaDHeJOhagenAVallatAVChemokine receptors in HIV-1 infection of the central nervous systemSemin Immunol19981032032139653047
   PubMed Web of Science ®Google Scholar
• McManusCMWeidenheimKWoodmanSEChemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulationAmer J Pathol200015641441145310751368
   PubMed Web of Science ®Google Scholar
• ConantKGarzino-DemoANathAInduction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementiaProc Natl Acad Sci U S A1998956311731219501225
   PubMed Web of Science ®Google Scholar
• KelderWMcArthurJCNance-SprosonTMcClernonDGriffinDEBeta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementiaAnn Neurol19984458318359818943
   PubMed Web of Science ®Google Scholar
• SandersVJPittmanCAWhiteMGWangGWileyCAAchimCLChemokines and receptors in HIV encephalitisAIDS (London, England)199812910211026
   PubMed Web of Science ®Google Scholar
• SassevilleVGSmithMMMackayCRChemokine expression in simian immunodeficiency virus-induced AIDS encephalitisAm J Pathol19961495145914678909235
   PubMed Web of Science ®Google Scholar
• EugeninEAOsieckiKLopezLGoldsteinHCalderonTMBermanJWCCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood–brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDSJ Neurosci20062641098110616436595
   PubMed Web of Science ®Google Scholar
• Yla-HerttualaSLiptonBARosenfeldMEExpression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesionsProc Natl Acad Sci U S A19918812525252562052604
   PubMed Web of Science ®Google Scholar
• SozzaniSIntronaMBernasconiSMCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expressionJ Leukoc Biol199762130339225989
   PubMed Web of Science ®Google Scholar
• VilligerPMTerkeltaubRLotzMMonocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acidJ Clin Invest19929024884961365641
   PubMed Web of Science ®Google Scholar
• KitchenSGKorinYDRothMDLandayAZackJACostimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infectionJ Virol19987211905490609765450
   PubMed Web of Science ®Google Scholar
• ZlozaASullivanYBConnickELandayALAl-HarthiLCD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIVBlood200310262156216412791668
   PubMed Web of Science ®Google Scholar
• AncutaPMosesAGabuzdaDTransendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditionsImmunobiology20042091–2112015481136
   PubMed Web of Science ®Google Scholar
• AncutaPWangJGabuzdaDCD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cellsJ Leuko Biol20068051156116417056766
   PubMed Web of Science ®Google Scholar
• DhawanSWeeksBSSoderlandCHIV-1 infection alters monocyte interactions with human microvascular endothelial cellsJ Immunol199515414224327527819
   PubMed Web of Science ®Google Scholar
• StentGCroweSMEffects of HIV-1 on the surface expression of LFA-1 on cultured monocytesJ Acquir Immune Defic Syndr Hum Retrovirol1997152951039241107
   PubMedGoogle Scholar
• NottetHSPersidskyYSassevilleVGMechanisms for the transendothelial migration of HIV-1-infected monocytes into brainJ Immunol19961563128412958558009
   PubMed Web of Science ®Google Scholar
• SeilheanDDzia-LepfoundzouASazdovitchVAstrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complexNeuropathol Appl Neurobiol199723283929160893
   PubMed Web of Science ®Google Scholar
• EugeninEAGamssRBucknerCShedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDSJ Leukoc Biol200679344445216507710
   PubMed Web of Science ®Google Scholar
• MullerWAWeiglSADengXPhillipsDMPECAM-1 is required for transendothelial migration of leukocytesJ Exp Med199317824494608340753
   PubMed Web of Science ®Google Scholar
• LosyJNiezgodaAWenderMIncreased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesionsJ Neuroimmunol199999216917210505971
   PubMed Web of Science ®Google Scholar
• LaBrancheCCHoffmanTLRomanoJDeterminants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificityJ Virol19997312103101031910559349
   PubMed Web of Science ®Google Scholar
• Aggoun-ZouaouiDCharriaut-MarlangueCRiveraSJorqueraIBen-AriYRepresaAThe HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slicesNeuroreport1996724334368730799
   PubMed Web of Science ®Google Scholar
• MeucciOMillerRJgp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1J Neurosci19961613408040888753870
   PubMed Web of Science ®Google Scholar
• OhagenADevittAKunstmanKJGenetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDSJournal Virol200377221233612345
   Web of Science ®Google Scholar
• OhagenAGhoshSHeJApoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelopeJ Virol19997328979069882290
   PubMed Web of Science ®Google Scholar
• PowerCMcArthurJCJohnsonRTDemented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequencesJ Virol1994687464346498207838
   PubMed Web of Science ®Google Scholar
• PowerCMcArthurJCNathANeuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsJ Virol19987211904590539765449
   PubMed Web of Science ®Google Scholar
• Van MarleGRourkeSBZhangKHIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brainAIDS (London, England)2002161419051914
   Web of Science ®Google Scholar
• JonesMVBellJENathAImmunolocalization of HIV envelope gp120 in HIV encephalitis with dementiaAIDS (London, England)2000141727092713
   Web of Science ®Google Scholar
• GorryPRDunfeeRLMeffordMEChanges in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygoteVirology2007362116317817239419
   PubMed Web of Science ®Google Scholar
• DunfeeRLThomasERWangJKunstmanKWolinskySMGabuzdaDLoss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementiaVirology2007367122223417599380
   PubMed Web of Science ®Google Scholar
• CorasanitiMTBagettaGRotirotiDNisticoGThe HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitroBiochem Pharmacol19985621531569698067
   PubMed Web of Science ®Google Scholar
• LeeCTomkowiczBFreedmanBDCollmanRGHIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathwaysJ Leukoc Biol20057841016102316081599
   PubMed Web of Science ®Google Scholar
• FantuzziLCaniniIBelardelliFGessaniSHIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanismJ Immunol200116695381538711313374
   PubMed Web of Science ®Google Scholar
• D’AversaTGEugeninEABermanJWNeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activationJ Neurosci Res200581343644615954144
   PubMed Web of Science ®Google Scholar
• ChangHCSamaniegoFNairBCBuonaguroLEnsoliBHIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic regionAIDS (London, England)1997111214211431
   PubMed Web of Science ®Google Scholar
• EnsoliBBarillariGSalahuddinSZGalloRCWong-StaalFTat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patientsNature1990345627084862184372
   PubMed Web of Science ®Google Scholar
• EnsoliBBuonaguroLBarillariGRelease, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivationJ Virol19936712772878416373
   PubMed Web of Science ®Google Scholar
• FrankelADPaboCOCellular uptake of the tat protein from human immunodeficiency virusCell1988556118911932849510
   PubMed Web of Science ®Google Scholar
• HudsonLLiuJNathADetection of the human immunodeficiency virus regulatory protein tat in CNS tissuesJ Neurovirol20006214515510822328
   PubMed Web of Science ®Google Scholar
• WielandUKuhnJEJassoyCRubsamen-WaigmannHWolberVBraunRWAntibodies to recombinant HIV-1 vif, tat, and nef proteins in human seraMed Microbiol Immunol199017911112184337
   PubMed Web of Science ®Google Scholar
• WestendorpMOFrankROchsenbauerCSensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120Nature199537565314975007539892
   PubMed Web of Science ®Google Scholar
• VogelBELeeSJHildebrandAA novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectinJ Cell Biol199312124614687682219
   PubMed Web of Science ®Google Scholar
• AlbiniASoldiRGiunciuglioDThe angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cellsNat Med1996212137113758946838
   PubMed Web of Science ®Google Scholar
• LiuYJonesMHingtgenCMUptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligandsNat Med20006121380138711100124
   PubMed Web of Science ®Google Scholar
• PuHTianJFloraGHIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brainMol Cell Neurosci200324122423714550782
   PubMed Web of Science ®Google Scholar
• KingJEEugeninEABucknerCMBermanJWHIV tat and neurotoxicityMicrobes Infect2006851347135716697675
   PubMed Web of Science ®Google Scholar
• RappaportJJosephJCroulSMolecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, TatJ Leukoc Biol199965445846510204574
   PubMed Web of Science ®Google Scholar
• JonesMOlafsonKDel BigioMRPeelingJNathAIntraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargementJ Neuropathol Exp Neurol19985765635709630236
   PubMed Web of Science ®Google Scholar
• MagnusonDSKnudsenBEGeigerJDBrownstoneRMNathAHuman immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicityAnn Neurol19953733733807695237
   PubMed Web of Science ®Google Scholar
• NathAPsooyKMartinCIdentification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxicJ Virol1996703147514808627665
   PubMed Web of Science ®Google Scholar
• NewDRMaMEpsteinLGNathAGelbardHAHuman immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron culturesJ Neurovirol1997321681739111179
   PubMed Web of Science ®Google Scholar
• SabatierJMVivesEMabroukKEvidence for neurotoxic activity of tat from human immunodeficiency virus type 1J Virol19916529619671898974
   PubMed Web of Science ®Google Scholar
• ShiBRainaJLorenzoABusciglioJGabuzdaDNeuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementiaJ Neurovirol1998432812909639071
   PubMed Web of Science ®Google Scholar
• StrijbosPJZamaniMRRothwellNJArbuthnottGHarkissGNeurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virusNeurosci Lett199519732152188552302
   PubMed Web of Science ®Google Scholar
• WeeksBSLiebermanDMJohnsonBNeurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49–58 basic domainJ Neurosci Res199542134408531224
   PubMed Web of Science ®Google Scholar
• EugeninEAD’AversaTGLopezLCalderonTMBermanJWMCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosisJ Neurochem20038551299131112753088
   PubMed Web of Science ®Google Scholar
• EugeninEAKingJENathAHIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytesProc Natl Acad Sci U S A200710493438344317360663
   PubMed Web of Science ®Google Scholar
• WangPBarksJDSilversteinFSTat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal ratsNeuroscience199988258559710197777
   PubMed Web of Science ®Google Scholar
• HaugheyNJNathAMattsonMPSlevinJTGeigerJDHIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicityJ Neurochem200178345746711483648
   PubMed Web of Science ®Google Scholar
• BonaviaRBajettoABarberoSAlbiniANoonanDMSchettiniGHIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neuronsBiochem Biophys Res Commun2001288230130811606043
   PubMed Web of Science ®Google Scholar
• StrittmatterWJSaundersAMSchmechelDApolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer diseaseProc Natl Acad Sci U S A1993905197719818446617
   PubMed Web of Science ®Google Scholar
• SlooterAJTangMXvan DuijnCMApolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigationJ Amer Med Assoc199727710818821
   Web of Science ®Google Scholar
• AlbertsMJGraffagninoCMcClennyCApoE genotype and survival from intracerebral haemorrhageLancet199534689745757658797
   PubMed Web of Science ®Google Scholar
• TardiffBENewmanMFSaundersAMPreliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart CenterAnn Thorac Surg19976437157209307463
   PubMed Web of Science ®Google Scholar
• CorderEHLannfeltLBogdanovicNFratiglioniLMoriHThe role of APOE polymorphisms in late-onset dementiasCell Mol Life Sci19985499289349791536
   PubMed Web of Science ®Google Scholar
• BurtTDAganBKMarconiVCApolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionProc Natl Acad Sci U S A2008105258718872318562290
   PubMed Web of Science ®Google Scholar
• ShariefMKCiardiMThompsonEJTumour necrosis factor-alpha mediates blood–brain barrier damage in HIV-1 infection of the central nervous systemMediators Inflamm19921319119618475460
   PubMedGoogle Scholar
• AchimCLHeyesMPWileyCAQuantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brainsJ Clin Invest1993916276927758514884
   PubMed Web of Science ®Google Scholar
• PerrellaOGuerrieroMIzzoESosciaMCarrieriPBInterleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous systemArquivos de neuro-psiquiatria19925021801821308387
   PubMedGoogle Scholar
• Gonzalez-ScaranoFMartin-GarciaJThe neuropathogenesis of AIDSNat Rev Immunol200551698115630430
   PubMed Web of Science ®Google Scholar
• ChunTWEngelDMizellSBEhlerLAFauciASInduction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokinesJ Exp Med1998188183919653086
   PubMed Web of Science ®Google Scholar
• SriramKO’CallaghanJPDivergent roles for tumor necrosis factor-alpha in the brainJ Neuroimmune Pharmacol20072214015318040839
   PubMed Web of Science ®Google Scholar
• EugeninEAGaskillPJBermanJWTunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV traffickingCell Immunol2009254214214818835599
   PubMed Web of Science ®Google Scholar
• EugeninEAGaskillPJBermanJWTunneling nanotubes (TNT): A potential mechanism for intercellular HIV traffickingCommunicative and Integrative Biology20092324324419641744
   PubMedGoogle Scholar
• GerdesHHBukoreshtlievNVBarrosoJFTunneling nanotubes: a new route for the exchange of components between animal cellsFEBS Letters2007581112194220117433307
   PubMed Web of Science ®Google Scholar
• OnfeltBDavisDMCan membrane nanotubes facilitate communication between immune cells?Biochem Soc Trans200432Pt 567667815493985
   PubMed Web of Science ®Google Scholar
• OnfeltBPurbhooMANedvetzkiSSowinskiSDavisDMLongdistance calls between cells connected by tunneling nanotubulesSci STKE20052005313pe5516333019
   PubMedGoogle Scholar
• RustomASaffrichRMarkovicIWaltherPGerdesHHNanotubular highways for intercellular organelle transportScience (New York, N.)2004303566010071010
   PubMed Web of Science ®Google Scholar
• SaezJCBerthoudVMBranesMCMartinezADBeyerECPlasma membrane channels formed by connexins: their regulation and functionsPhysiol Rev20038341359140014506308
   PubMed Web of Science ®Google Scholar
• WilleckeKEibergerJDegenJStructural and functional diversity of connexin genes in the mouse and human genomeBiol Chem2002383572573712108537
   PubMed Web of Science ®Google Scholar
• BennettMVRubinJBBargielloTAVerselisVKStructure-function studies of voltage sensitivity of connexins, the family of gap junction forming proteinsJpn J Physiol199343 Suppl 1S301S3108271512
   PubMedGoogle Scholar
• HarrisALBevansCGExploring hemichannel permeability in vitroMethods Mol Biol200115435737711218659
   PubMedGoogle Scholar
• BennettMVZukinRSElectrical coupling and neuronal synchronization in the Mammalian brainNeuron200441449551114980200
   PubMed Web of Science ®Google Scholar
• RouachNAvignoneEMemeWGap junctions and connexin expression in the normal and pathological central nervous systemBiol Cell2002947–845747512566220
   PubMed Web of Science ®Google Scholar
• KielianTEsenNEffects of neuroinflammation on glia-glia gap junctional intercellular communication: a perspectiveNeurochem Int2004452–342943615145557
   PubMed Web of Science ®Google Scholar
• EugeninEABranesMCBermanJWSaezJCTNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responsesJ Immunol200317031320132812538692
   PubMed Web of Science ®Google Scholar
• El-SabbanMEMerhiRAHaidarHAHuman T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cellsBlood20029993383338911964307
   PubMed Web of Science ®Google Scholar
• OnfeltBNedvetzkiSBenningerRKStructurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteriaJ Immunol2006177128476848317142745
   PubMed Web of Science ®Google Scholar
• OnfeltBNedvetzkiSYanagiKDavisDMCutting edge: Membrane nanotubes connect immune cellsJ Immunol200417331511151315265877
   PubMed Web of Science ®Google Scholar
• MagalhaesACBaronGSLeeKSUptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cellsJ Neurosci200525215207521615917460
   PubMed Web of Science ®Google Scholar
• WatkinsSCSalterRDFunctional connectivity between immune cells mediated by tunneling nanotubulesImmunity200523330931816169503
   PubMed Web of Science ®Google Scholar
• ShererNMLehmannMJJimenez-SotoLFHorensavitzCPypaertMMothesWRetroviruses can establish filopodial bridges for efficient cell-to-cell transmissionNat Cell Biol20079331031517293854
   PubMed Web of Science ®Google Scholar
• HaseKKimuraSTakatsuHM-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complexNat Cell Biol200911121427143219935652
   PubMed Web of Science ®Google Scholar
• XuWSantiniPASullivanJSHIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsNat Immunol20091091008101719648924
   PubMed Web of Science ®Google Scholar
• DouHGrotepasCBMcMillanJMMacrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDSJ Immunol2009183166166919535632
   PubMed Web of Science ®Google Scholar
• DouHMoreheadJDestacheCJLaboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesVirology2007358114815816997345
   PubMed Web of Science ®Google Scholar
• HansonLRFreyWH2ndStrategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDSJ Neuroimmune Pharmacol200721818618040829
   PubMed Web of Science ®Google Scholar
• AnsariKSYuPHKruckTPTattonWGRescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibitionJ Neurosci1993139404240538366359
   PubMed Web of Science ®Google Scholar
• CarrilloMCKitaniKKanaiSSatoYMiyasakaKIvyGO(−) Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male miceLife Sci199454149759818139387
   PubMed Web of Science ®Google Scholar
• MatsuiYKumagaeYMonoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemiaNeurosci Lett199112621751781922929
   PubMed Web of Science ®Google Scholar
• SaloPTTattonWGDeprenyl reduces the death of motoneurons caused by axotomyJ Neurosci Res19923123944001374134
   PubMed Web of Science ®Google Scholar
• TattonWGGreenwoodCERescue of dying neurons: a new action for deprenyl in MPTP parkinsonismJ Neurosci Res19913046666721686284
   PubMed Web of Science ®Google Scholar
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairmentDana Consortium on the Therapy of HIV Dementia and Related Cognitive DisordersNeurology19985036456519521250
   PubMed Web of Science ®Google Scholar
• SacktorNSchifittoGMcDermottMPMarderKMcArthurJCKieburtzKTransdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled studyNeurology200054123323510636157
   PubMed Web of Science ®Google Scholar
• SchifittoGYiannoutsosCTErnstTSelegiline and oxidative stress in HIV-associated cognitive impairmentNeurology2009
   Web of Science ®Google Scholar
• SchifittoGZhangJEvansSRA multicenter trial of selegiline transdermal system for HIV-associated cognitive impairmentNeurology200769131314132117652642
   PubMed Web of Science ®Google Scholar
• AgrawalLLouboutinJPReyesBAVan BockstaeleEJStrayerDSAntioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosisGene Ther200613231645165616871233
   PubMed Web of Science ®Google Scholar
• LouboutinJPAgrawalLReyesBAVan BockstaeleEJStrayerDSProtecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectorsGene Ther200714231650166117914406
   PubMed Web of Science ®Google Scholar
• LouboutinJPAgrawalLReyesBAVan BockstaeleEJStrayerDSHIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymesNeurobiol Dis200934346247619327399
   PubMed Web of Science ®Google Scholar
• AgrawalLLouboutinJPStrayerDSPreventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implicationsVirology2007363246247217336361
   PubMed Web of Science ®Google Scholar
• SapadinANFleischmajerRTetracyclines: nonantibiotic properties and their clinical implicationsJ Am Acad Dermatol200654225826516443056
   PubMed Web of Science ®Google Scholar
• ElewaHFHilaliHHessDCMachadoLSFaganSCMinocycline for short-term neuroprotectionPharmacotherapy200626451552116553511
   PubMed Web of Science ®Google Scholar
• StirlingDPKoochesfahaniKMSteevesJDTetzlaffWMinocycline as a neuroprotective agentNeuroscientist200511430832216061518
   PubMed Web of Science ®Google Scholar
• FollstaedtSCBarberSAZinkMCMechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1J Neurovirol200814537638819003592
   PubMed Web of Science ®Google Scholar
• ZinkMCUhrlaubJDeWittJNeuroprotective and anti-human immunodeficiency virus activity of minocyclineJ Amer Med Assoc20052931620032011
   PubMed Web of Science ®Google Scholar
• LiptonSAParadigm shift in neuroprotection by NMDA receptor blockade: memantine and beyondNat Rev Drug Discov20065216017016424917
   PubMed Web of Science ®Google Scholar
• FleischhackerWWBuchgeherASchubertHMemantine in the treatment of senile dementia of the Alzheimer typeProg Neuropsychopharmacol Biol Psychiatry198610187933517967
   PubMed Web of Science ®Google Scholar
• WinbladBPoritisNMemantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)Int J Geriatr Psych1999142135146
   PubMed Web of Science ®Google Scholar
• RabeyJMNissipeanuPKorczynADEfficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson’s diseaseJ Neural Transm19924277282
   Web of Science ®Google Scholar
• ReisbergBDoodyRStofflerASchmittFFerrisSMobiusHJMemantine in moderate-to-severe Alzheimer’s diseaseNew Engl J Med2003348141333134112672860
   PubMed Web of Science ®Google Scholar
• TariotPNFarlowMRGrossbergGTGrahamSMMcDonaldSGergelIMemantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trialJ Amer Med Assoc20042913317324
   PubMed Web of Science ®Google Scholar
• ToggasSMMasliahEMuckeLPrevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantineBrain Research199670623033078822372
   PubMed Web of Science ®Google Scholar
• LiptonSAMemantine prevents HIV coat protein-induced neuronal injury in vitroNeurology1992427140314051620355
   PubMed Web of Science ®Google Scholar
• NathAHaugheyNJJonesMAndersonCBellJEGeigerJDSynergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantineAnn Neurol200047218619410665489
   PubMed Web of Science ®Google Scholar
• AndersonERGendelmanHEXiongHMemantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitisJ Neurosci200424327194719815306653
   PubMed Web of Science ®Google Scholar
• SchifittoGNaviaBAYiannoutsosCTMemantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy studyAIDS (London, England)2007211418771886
   PubMed Web of Science ®Google Scholar